作者：
Sahar,Khan [1]
;
Debra J,Bergstrom [2]
;
Julie,Côté [3]
;
Rami,Kotb [4]
;
Richard,LeBlanc [5]
;
Martha L,Louzada [6]
;
Hira S,Mian [7]
;
Ibraheem,Othman [8]
;
Gabriele,Colasurdo [9]
;
Alissa,Visram [10]
作者单位：
Windsor Regional Hospital, University of Western Ontario, Windsor, Ontario, Canada. Electronic address: sahar.khan@wrh.on.ca.
[1]
Division of Hematology, Memorial University of Newfoundland, Newfoundland and Labrador, Canada.
[2]
Centre Hospitalier Universitaire de Québec, Quebec, Quebec, Canada.
[3]
Department of Medical Oncology and Hematology, CancerCare Manitoba, University of Manitoba, Winnipeg, Manitoba, Canada.
[4]
Hôpital Maisonneuve-Rosemont, University of Montreal, Montreal, Quebec, Canada.
[5]
London Health Sciences Centre, Western University, London, Ontario, Canada.
[6]
Juravinski Cancer Centre, McMaster University, Hamilton, Ontario, Canada.
[7]
Allan Blair Cancer Centre, University of Saskatchewan, Regina, Saskatchewan, Canada.
[8]
Myeloma Canada, Dorval, Quebec, Canada.
[9]
The Ottawa Hospital, University of Ottawa, Ottawa, Ontario, Canada.
[10]
DOI
10.1016/j.clml.2024.10.012
PMID
39567294
发布时间
2024-11-20
换一批
换一批
